Despite no selection performed at enrolment, patients in the AZD7442 group were found to have very low IgA serum levels and more defective post-immunization serological responses, two well-known risk factors for SARS-CoV-2 and other respiratory infections (10, 28, 40). Here, CD79A is linked to respiratory tract infectious disorder.